$2.41 -0.01 (-0.41%)
11/6/2009 4:00 PM

SuperGen, Inc. (SUPG)

CAPS Rating: 5 out of 5

A pharmaceutical company dedicated to the discovery, development and commercialization of therapies to treat patients with cancer.

Current Price $2.41 Mkt Cap $142.55M
Open $0.00 P/E Ratio 7.30
Prev. Close $2.42 Div. (Yield) N/A (N/A)
Daily Range $2.40 - $2.45 Volume 174,204
52-Wk Range $1.54 - $3.30 Avg. Daily Vol. 243,000

SUPG News and Commentary

Caps

How do you think SUPG will perform vs the S&P 500?

Add Stock to Watchlist

All Members

187 Outperform
7 Underperform
 

All-Star Members

48 Outperform
2 Underperform
 

Wall Street

4 Outperform
1 Underperform
 

Top SUPG Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

smitty012 (69.41)
Submitted January 12, 2007

TradingMarkets.com:
Low-Priced Stocks Ready to Surge: These are the stocks under $10/share that today made new 10-day lows that are still in an uptrend as they are trading above their 200-day moving average. They are sorted in rank according to… More

0 Comments | Reply | Report this Post

zzlangerhans (99.36)
Submitted December 01, 2008

I lost my bet that Dacogen would show a survival benefit similar to Vidaza. I find the rebound in Supergen stock inexplicable given an absence of positive catalysts. I expect that losses will continue to widen as Dacogen loses market share and the… More

0 Comments | Reply | Report this Post
SUPG VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about SUPG.

Recs

0
Member Avatar libertybrewcity (< 20) Submitted: 11/2/2009 5:13:10 PM : Outperform Start Price: $2.37 SUPG Score: -1.58

lots of cash, pipeline with good potential

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar topsecret10 (46.74) Submitted: 10/13/2009 6:32:30 PM : Outperform Start Price: $2.56 SUPG Score: -4.40

Lots of Insider buying here..... SuperGen is a pharmaceutical company whose mission is to prolong, improve the quality of and ultimately, save the lives of those people afflicted with life-threatening diseases, especially cancer.
The company possesses a broad portfolio of proprietary cancer therapies that target a variety of solid tumors, hematological malignancies and blood disorders, offering renewed hope to patients who suffer from these illnesses.
The company is led by a seasoned management team with extensive experience in all aspects of the oncology pharmaceutical industry. TS

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar recklessfier (81.13) Submitted: 10/13/2009 1:42:24 AM : Outperform Start Price: $2.61 SUPG Score: -7.42

portefeuille

Report this Post 0 Comments | Reply | Permalink
View All 24 Pitches »

Leaderboard

Find the members with the highest scoring picks in SUPG.

Score Leader

ButtSauce

ButtSauce (99.47) Score: +57.12

The Score Leader is the member with the highest score across all their picks in SUPG.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
spicebyr 90.22 8/25/2008 Outperform 1Y $1.81 +33.15% -14.20% +47.35
hayrettin 78.73 7/2/2008 Outperform NS $1.80 +33.89% -13.11% +46.99
michael53mail < 20 8/4/2008 Outperform NS $1.81 +33.15% -12.33% +45.48
mwoftbl < 20 7/25/2008 Outperform 3Y $1.82 +32.42% -12.26% +44.67
hibetals 97.82 3/7/2007 Underperform NS $5.40 -55.37% -18.54% +36.83
cockeagledrvr 48.66 9/29/2006 Underperform 1Y $4.75 -49.26% -15.00% +34.27
heavenlyfood 53.09 11/10/2008 Outperform NS $1.73 +39.31% +15.50% +23.81
biovestor < 20 6/30/2008 Outperform 1Y $2.20 +9.55% -13.59% +23.14 1 Comment
BFR4570 36.13 6/3/2008 Outperform NS $2.43 -0.82% -19.42% +18.60
holup3409 93.40 2/25/2008 Outperform 5Y $2.42 -0.41% -18.71% +18.30
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackMerriman < 20 3/31/2009 Outperform NS $1.75 +37.71% +36.06% +1.66
TrackRodmanRen < 20 7/2/2008 Outperform NS $2.15 +12.09% -14.26% +26.36
TrackSusquehanna 74.76 7/2/2008 Outperform NS $2.15 +12.09% -14.26% +26.36
TrackSusquehanna 74.76 12/7/2007 Underperform NS $4.33 -36.49% -8.95% +27.54 2/27/2008 @ $2.75
TrackBroadpoint.AmTech 73.02 9/5/2007 Outperform NS $4.19 -42.48% -23.83% -18.66
TrackJimCramer < 20 8/3/2007 Underperform 3W $5.04 -52.18% -21.61% +30.58

Featured Broker Partners